A Trial Investigating the Pharmacodynamic Properties of NN1218 in Subjects With Type 1 Diabetes

Exclusion Criteria

• •Subject who has donated any blood or plasma in the past month or more than 500 mL within 3 months prior to trial start
• •Smoker (defined as a subject who is smoking more than 5 cigarettes or the equivalent per day)
• •Not able or willing to refrain from smoking and use of nicotine substitute products during the inpatient period